Asco 2015 – SWOG S1310: Randomized phase II trial of single agent MEK

Discussion Board › Forums › Chemotherapy & More › Asco 2015 – SWOG S1310: Randomized phase II trial of single agent MEK

Viewing 2 posts - 1 through 2 (of 2 total)
  • Author
    Posts
  • May 14, 2015 at 8:31 pm #87994
    surfer1
    Spectator

    We just met with a doctor yesterday and this one came up. It is suspended right now, but he had said they were showing some promise with it. Hopefully they figure out the issues and reopen it.

    May 13, 2015 at 9:34 pm #11241
    gavin
    Moderator

    SWOG S1310: Randomized phase II trial of single agent MEK inhibitor trametinib vs. 5-fluorouracil or capecitabine in refractory advanced biliary cancer.

    http://abstracts.asco.org/156/AbstView_156_150637.html

  • Author
    Posts
Viewing 2 posts - 1 through 2 (of 2 total)
  • The forum ‘Chemotherapy & More’ is closed to new topics and replies.